7500 Participants Needed

New Mammography Technology for Breast Cancer Screening

Recruiting at 3 trial locations
AC
MM
SW
GT
Overseen ByGeena Thomas
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Hologic, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial is testing a new device designed to help screen for and diagnose breast cancer. It targets individuals who are undergoing breast cancer screening and diagnosis. The device works by scanning breast tissue to identify any unusual changes or lumps that could indicate cancer.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the IzoView Breast CT Imaging System treatment for breast cancer screening?

Research on breast CT systems shows promising results, with excellent anatomical detail and good visualization of tumors, similar to the IzoView system. Initial studies indicate that breast CT can effectively enhance tumor visualization, especially with iodine contrast, suggesting it may play a role in breast cancer imaging.12345

Is the IzoView Breast CT Imaging System safe for humans?

The breast CT system, including the IzoView, has been tested on 55 women, including healthy volunteers and those with a high likelihood of breast cancer, using radiation doses similar to standard mammography. Initial results show promising imaging quality, and the system is undergoing further safety and performance evaluations.13567

How is the IzoView Breast CT Imaging System different from other breast cancer screening treatments?

The IzoView Breast CT Imaging System is unique because it uses a dedicated computed tomography (CT) system to scan the breast in a pendant position, providing detailed 3D images without compressing the breast, unlike traditional mammography. This method offers excellent anatomical detail and visualization of soft tissue and microcalcifications, potentially improving the detection of breast cancer, especially in dense breast tissue.13689

Eligibility Criteria

This trial is for women at least 35 years old who need a mammogram or breast biopsy, regardless of race and ethnicity. It's not for those who may be pregnant, cannot stand independently due to being wheelchair-bound, have breast implants, pacemakers, or IV ports in the area where the mammogram takes pictures, or have been in this study before.

Inclusion Criteria

I am due for a mammogram or breast biopsy.
I am at least 35 years old.
I am a woman.

Exclusion Criteria

Has breast implants, cardiac pacemakers, or IV ports in the mammography field of view
I use a wheelchair and cannot stand on my own.
Previously participated in the study
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo investigational mammogram exams to evaluate the safety and efficacy of the device

4 years

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Investigational Device
Trial OverviewThe study is testing new mammography technology aimed at improving breast cancer screening and diagnosis. The goal is to determine how safe and effective this new device is compared to current methods.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Investigational Mammogram ExamExperimental Treatment1 Intervention
All subjects that are indicated for a screening or diagnostic mammogram or breast biopsy.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hologic, Inc.

Lead Sponsor

Trials
48
Recruited
59,900+

Findings from Research

Breast CT imaging, utilizing advanced cone beam technology, is being developed as a promising alternative to traditional mammography, particularly due to its ability to reduce imaging artifacts and improve image quality.
A new prototype system for breast CT is being designed for image-guided interventional procedures, with plans for a multi-institutional clinical trial to evaluate its effectiveness in breast imaging.
An X-Ray computed tomography/positron emission tomography system designed specifically for breast imaging.Boone, JM., Yang, K., Burkett, GW., et al.[2022]
Digital breast tomosynthesis is being increasingly adopted in breast imaging clinics due to its potential to overcome limitations of traditional mammography, as supported by early clinical data.
The article provides insights into how to interpret digital breast tomosynthesis images and discusses considerations for its integration into routine clinical practice.
Clinical implementation of digital breast tomosynthesis.Conant, EF.[2021]
A dedicated breast CT system has been developed and tested on 55 women, showing excellent anatomical detail and visualization of tumors, especially when using iodine contrast, which enhances tumor detection.
The breast CT system is designed to use radiation doses comparable to standard two-view mammography, making it a potentially safe alternative for breast cancer screening.
Computed tomography for imaging the breast.Boone, JM., Kwan, AL., Yang, K., et al.[2019]

References

An X-Ray computed tomography/positron emission tomography system designed specifically for breast imaging. [2022]
Clinical implementation of digital breast tomosynthesis. [2021]
Computed tomography for imaging the breast. [2019]
[New mammography technologies and their impact on radiation dose]. [2016]
Breast cancer screening in average and high-risk women. [2022]
Emerging breast imaging modalities. [2012]
Ultrasound of the whole breast utilizing a dedicated automated breast scanner. [2022]
Dedicated breast computed tomography: Basic aspects. [2017]
Tomosynthesis for breast cancer screening. [2018]